Showing results (851-860 of 1,482) with videos related to
Sort By:
Pageof 149
Human Psychopharmacology|December 25, 2009
The effect of dopamine partial agonists on the nicotine dependency in patients with schizophreniaSe Hee Kim, Doug Hyun Han, So Youn Joo, et al.Human Psychopharmacology|December 31, 2009
Lorazepam modulates orbitofrontal signal changes during emotional processing in catatoniaAndre Richter, Simone Grimm, Georg NorthoffHuman Psychopharmacology|December 31, 2009
Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacyBernardo Dell'Osso, Massimiliano Buoli, David S Baldwin, et al.Human Psychopharmacology|June 29, 2017
Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)Marc Grifell, Mireia Ventura, Xoán Carbón, et al.Human Psychopharmacology|December 1, 2005
Alcohol and/or benzodiazepine use: different accidents--different impacts?Ilsemarie Kurzthaler, Markus Wambacher, Karl Golser, et al.Human Psychopharmacology|March 3, 2010
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot studyArnim Quante, Sara Zeugmann, Alexander Luborzewski, et al.Human Psychopharmacology|March 3, 2010
Ultrasonically determined thyroid volume and thyroid functions in lithium-naïve and lithium-treated patients with bipolar disorder: a cross-sectional and longitudinal studySaliha Ozsoy, Ertugrul Mavili, Murat Aydin, et al.Human Psychopharmacology|June 15, 2018
Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trialAlireza Ghajar, Faezeh Gholamian, Maryam Tabatabei-Motlagh, et al.Human Psychopharmacology|October 9, 2003
Saccade and cognitive impairment associated with kava intoxicationSheree Cairney, Paul Maruff, Alan R Clough, et al.Human Psychopharmacology|October 9, 2003
Stem-completion tasks (indirect, direct inclusion and exclusion) are differently affected by equipotent doses of lorazepam and flunitrazepamS Pompéia, O F A Bueno, J C F Galduróz, et al.Pageof 149